Treatment of nonmetastatic cranial parameningeal rhabdomyosarcoma in children younger than 3 years old: Results from international society of pediatric oncology studies MMT 89 and 95

Journal of Clinical Oncology

Volumn 27, Issue 8, 2009, Pages 1310-1315

  Defachelles, Anne Sophie ^a   Rey, Annie ^a   Oberlin, Odile ^a   Spooner, David ^a   Stevens, Michael C G ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; DACTINOMYCIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE;

ARTICLE; CANCER CONTROL; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PARAMENINGEAL DISORDER; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; RHABDOMYOSARCOMA; TREATMENT RESPONSE;

BRAIN NEOPLASMS; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INFANT; MALE; PROGNOSIS; RHABDOMYOSARCOMA;

EID: 62449192357     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.19.5701     Document Type: Article

References (28)

1. Crist WM, Anderson JR, Meza JL, et al: Intergroup rhabdomyosarcoma study-IV: Results for patients with nonmetastatic disease. J Clin Oncol 19:3091-3102, 2001
2. Stevens MC, Rey A, Bouvet N, et al: Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: Third study of the International Society of Pediatric Oncology - SIOP Malignant Mesenchymal Tumor 89. J Clin Oncol 23:2618-2628, 2005
3. Tefft M, Fernandez C, Donaldson M, et al: Incidence of meningeal involvement by rhabdomyosarcoma of the head and neck in children: A report of the Intergroup Rhabdomyosarcoma Study (IRS). Cancer 42:253-258, 1978
4. Benk V, Rodary C, Donaldson SS, et al: Para-meningeal rhabdomyosarcoma: Results of an international workshop. Int J Radiat Oncol Biol Phys 36:533-540, 1996
5. Raney RB, Meza J, Anderson JR, et al: Treatment of children and adolescents with localized parameningeal sarcoma: Experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through IV, 1978-1997. Med Pediatr Oncol 38:22-32, 2002
6. Pappo AS, Meza JL, Donaldson SS, et al: Treatment of localized non-orbital, non parameningeal head and neck rhabdomyosarcoma: Lessons learned from intergroup rhabdomyosarcoma studies III and IV. J Clin Oncol 21:638-645, 2003
7. Raney RB, Asmar L, Vassilopoulou-Sellin R, et al: Late complications of therapy in 213 children with localized non orbital soft-tissue sarcoma of the head and neck: A descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and -III - IRS Group of the Children's Cancer Group and the Pediatric Oncology Group. Med Pediatr Oncol 33:362-371, 1999
8. Paulino AC, Simon JH, Zhen W, et al: Long-term effects in children treated with radiotherapy for head and neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys 48:1489-1495, 2000
9. Michalski JM, Sur RK, Harms WB, et al: Three dimensional conformal radiation therapy in pediatric parameningeal rhabdomyosarcomas. Int J Radiat Oncol Biol Phys 33:985-991, 1995
10. Paulino AC, Skwarchuk M: Intensity-modulated radiation therapy in the treatment of children. Med Dosim 27:115-120, 2002
11. Meazza C, Ferrari A, Casanova M, et al: Evolving treatment strategies for parameningeal rhabdomyosarcoma: The experience of the Instituto Nazionale Tumori of Milan. Head Neck 27:49-57, 2005
12. Stevens M, Rey A, Bouvet N, et al: SIOP MMT 95: Intensified (6 drug) versus standard (IVA) chemotherapy for high risk non metastatic rhabdomyosarcoma (RMS). J Clin Oncol 15:802s, 2004 (suppl; abstr 8515)
13. Rodary C, Flamant F, Donaldson SS: An attempt to use a common staging system in rhabdomyosarcoma: A report of an international workshop initiated by the International Society of Pediatric Oncology (SIOP). Med Pediatr Oncol 17:210-215, 1989
14. Maurer HM, Beltangady M, Gehan EA, et al: The Intergroup Rhabdomyosarcoma Study-I: A final report. Cancer 61:209-220, 1988
15. Newton WA Jr, Gehan EA, Webber BL, et al: Classification of rhabdomyosarcomas and related sarcomas: Pathologic aspects and proposal for a new classification - An Intergroup Rhabdomyosarcoma Study. Cancer 76:1073-1085, 1995
16. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
17. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomised clinical trials requiring prolonged observation of each patient. Br J Cancer 35:1-39, 1977
18. Cox DR: Regression models and life tables. J R Stat Soc B 34:187-220, 1972
19. Flamant F, Rodary C, Rey A, et al: Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence: Results of the second study of the International Society of Paediatric Oncology: MMT84. Eur J Cancer 34:1050-1062, 1998
20. Raney RB, Tefft M, Newton WA, et al: Improved prognosis with intensive treatment of children with cranial soft tissue sarcomas arising in nonorbital parameningeal sites: A report from the Intergroup Rhabdomyosarcoma Study. Cancer 59:147-155, 1987
21. Wharam MD: Rhabdomyosarcoma of parameningeal sites. Semin Radiat Oncol 7:212-216, 1997
22. Stevens MCG: Treatment for childhood rhabdomyosarcoma: The cost of cure. Lancet Oncol 6:77-84, 2005
23. Denys D, Kaste SC, Kun LE, et al: The effects of radiation on craniofacial skeletal growth: A quantitative study. Int J Pediatr Otorhinolaryngol 45:7-13, 1998
24. Estilo CL, Huryn JM, Kraus DH, et al: Effects of therapy on dento-facial development in long-term survivors of head and neck rhabdomyosarcoma: The Memorial Sloan-Kettering Cancer Center experience. J Pediatr Hematol Oncol 25:215-222, 2003
25. Puri DR, Wexler LH, Meyers PA, et al: The challenging role of radiation therapy for very young children with rhabdomyosarcoma. Int J Radiat Oncol Biol Phys 65:1177-1184, 2006
26. Buwalda J, Schouwenburg PF, Blank LE, et al: A novel local treatment strategy for advanced stage head and neck rhabdomyosarcomas in children: Results of the AMORE protocol. Eur J Cancer 39: 1594-1602, 2003
27. Smith SC, Lindsley SK, Felgenhauer J, et al: Intensive induction chemotherapy and delayed irradiation in the management of parameningeal rhabdomyosarcoma. J Pediatr Hematol Oncol 25:774-779, 2003
28. Douglas JG, Arndt CA, Hawkins DS: Delayed radiotherapy following dose intensive chemotherapy for parameningeal rhabdomyosarcoma (PM-RMS) of childhood. Eur J Cancer 43:1045-1050, 2007